Status:
UNKNOWN
Retrospective Analysis of the Epidemiological Change and Determinants of Prognosis of Talaromycosisof Human Immunodeficiency Virus Negative Host in Guangxi
Lead Sponsor:
Guangxi Medical University
Collaborating Sponsors:
Second Affiliated Hospital of Guangzhou Medical University
The Fourth People's Hospital of Nanning
Conditions:
To Investigate the Characteristics and Prognostic Factors of T. Marneffei Infections and the Causes of Misdiagnosis
To Study the Recurrence Indicators and Establish a Therapeutic Effect Evaluation System of T. Marneffei Infections
Eligibility:
All Genders
Brief Summary
Through a multi-center large-sample retrospective study, the epidemiological changes of TSM in Guangxi have been reviewed, its incidence trend was understood to attract the attention of clinicians; th...
Eligibility Criteria
Inclusion
- Eligible patients were HIV-negative adults who had talaromycosis that was confirmed by either microscopy or culture.
Exclusion
- patients were HIV-infected adults who had talaromycosis that was confirmed by either microscopy or culture.
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT03819348
Start Date
January 1 2003
End Date
June 30 2019
Last Update
January 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangxi Medical University
Nanning, Guangxi, China, 530021